1. Home
  2. AORT vs PLSE Comparison

AORT vs PLSE Comparison

Compare AORT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$46.89

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$14.86

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
PLSE
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.2B
IPO Year
1993
2016

Fundamental Metrics

Financial Performance
Metric
AORT
PLSE
Price
$46.89
$14.86
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$49.36
$22.00
AVG Volume (30 Days)
377.8K
186.0K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,646,000.00
$86,000.00
Revenue This Year
$15.97
N/A
Revenue Next Year
$10.96
$1,002.94
P/E Ratio
N/A
N/A
Revenue Growth
9.81
N/A
52 Week Low
$21.97
$12.56
52 Week High
$48.25
$25.00

Technical Indicators

Market Signals
Indicator
AORT
PLSE
Relative Strength Index (RSI) 58.10 55.35
Support Level $45.41 $14.33
Resistance Level $48.25 $15.96
Average True Range (ATR) 1.41 0.73
MACD 0.16 0.23
Stochastic Oscillator 75.58 61.27

Price Performance

Historical Comparison
AORT
PLSE

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: